Cancer clinical trials in the region Grand Est
288 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Prostate cancer
#NCT07005154
#2024-517653-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
6 recruiting sites
Astellas Pharma Développement mondial, Inc.
Phase 2
Prostate cancer
#NCT07005154
#2024-517653-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at advanced or metastatic stage
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
6 recruiting sites
Astellas Pharma Développement mondial, Inc.
Phase 2
Breast cancer
#NCT04985266
Phase de surveillance de l’ADN tumoral circulant
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Positive
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Chemotherapy
Hormone therapy
Excluded previous treatments at localized stage
Targeted therapy
18 recruiting sites
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04602377
#2024-515310-40-01
Required histologic types
Other ovarian cancer
Required disease stage
Localized
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
6 recruiting sites
ARCAGY/ GINECO GROUP
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05872204
Required histologic types
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Other ovarian cancer
Required histologic sub types
Serous low grade carcinoma (LGSOC)
Endometrioid carcinoma
Stromal cells and sex cords tumor
Required HR statuses
HR Positive
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
6 recruiting sites
Universitaire Ziekenhuizen KU Leuven
Phase 2
Rectal cancer
#NCT04749108
#2021-000414-41
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
27 recruiting sites
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Stomach and esophageal cancer
#NCT07205731
Required histologic types
Esophagus
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
16 recruiting sites
CHU de Clermont-Ferrand
Phase 2
Lung cancer
#NCT06552234
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
ROS-1
Required number of previous lines of therapy for current stage of disease
None
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
17 recruiting sites
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
Colon cancer
Rectal cancer
#NCT04262687
Required disease stage
Metastatic
Required genetic anomalies
MSS/pMMR
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Surgery
Chemotherapy
Excluded genetic anomalies
MSI/dMMR
Excluded previous treatments at localized stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
51 recruiting sites
Fédération Francophone de Cancérologie Digestive
Phase 2
Breast cancer
#NCT06078384
#2023-504620-26-00
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Negative
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy
23 recruiting sites
UNICANCER